Cargando…
Inhibition of Mesothelin as a Novel Strategy for Targeting Cancer Cells
Mesothelin, a differentiation antigen present in a series of malignancies such as mesothelioma, ovarian, lung and pancreatic cancer, has been studied as a marker for diagnosis and a target for immunotherapy. We, however, were interested in evaluating the effects of direct targeting of Mesothelin on...
Autores principales: | Wang, Kun, Bodempudi, Vidya, Liu, Zhengian, Borrego-Diaz, Emma, Yamoutpoor, Farnaz, Meyer, Anna, Woo, Richard A., Pan, Weihong, Dudek, Arkadiusz Z., Olyaee, Mojtaba S., Esfandyari, Tuba, Farassati, Faris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317639/ https://www.ncbi.nlm.nih.gov/pubmed/22485139 http://dx.doi.org/10.1371/journal.pone.0033214 |
Ejemplares similares
-
Utilizing Ras Signaling Pathway to Direct Selective Replication of Herpes Simplex Virus-1
por: Pan, Weihong, et al.
Publicado: (2009) -
Cancer stem cells, the ultimate targets in cancer therapy
por: Shabbir, Ahmed, et al.
Publicado: (2018) -
Association of clinicopathologic characteristics and outcomes with EZH2 expression in patients with breast cancer in East Azerbaijan, Iran
por: Boostani, Farnaz, et al.
Publicado: (2018) -
Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors
por: Einama, Takahiro, et al.
Publicado: (2017) -
Targeting Cancer Stem Cells by Oncolytic Viruses and Nano-Mediated Delivery
por: Hosseini, Mahsa, et al.
Publicado: (2020)